FDA Delays Decision on Inhalable Insulin
Apr 07, 2014 PM EDT
The Food and Drug Administration has decided to delay their decision on Afrezza, a type of inhalable insulin designed to treat diabetics, by three months, buying themselves more time to consider the safety and effectiveness of the drug.